EuBiologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 18 shareholders own 21.19% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.7%	BioNote, Inc.	6,091,964	₩81.6b	0%	no data
3.17%	The Vanguard Group, Inc.	1,156,817	₩15.5b	0.01%	no data
0.44%	Dimensional Fund Advisors LP	160,658	₩2.2b	8.62%	no data
0.31%	Norges Bank Investment Management	113,121	₩1.5b	-67.6%	no data
0.16%	Charles Schwab Investment Management, Inc.	57,566	₩770.8m	0%	no data
0.14%	KB Asset Management Co., Ltd.	49,711	₩665.6m	-12%	0.01%
0.071%	State Street Global Advisors, Inc.	25,790	₩345.3m	-5.73%	no data
0.06%	Young-sik Jo	22,074	₩295.6m	0%	no data
0.05%	Innocence Co. Ltd	18,074	₩242.0m	0%	no data
0.047%	NH-Amundi Asset Management	17,088	₩228.8m	307%	0.01%
0.022%	Samsung Asset Management Company, Ltd.	8,147	₩109.1m	-98.3%	no data
0.0095%	Kiwoom Asset Management Co., Ltd.	3,461	₩46.4m	0%	no data
0.006%	Truston Asset Management Co., LTD.	2,197	₩29.4m	0%	0.01%
0.0042%	Midas Asset Management	1,527	₩20.5m	0%	no data
0.004%	Hanwha Asset Management Co. Ltd.	1,457	₩19.5m	0%	no data
0.00089%	Mirae Asset Global Investments Co., Ltd.	323	₩4.3m	-37%	no data
0.00052%	Invesco Capital Management LLC	188	₩2.5m	0%	no data
0.00001%	KOREITASSET Management Company Limited	5	₩48.9k	0%	no data